Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potential can be a tough task.
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.
FirstEnergy Corporation FE delivered third-quarter 2020 operating earnings of 84 cents per share, which beat the Zacks Consensus Estimate of 80 cents by 5%. Also, the bottom line rose 10.5% from the year-ago quarter’s figure.On a GAAP basis, the company’s earnings increased t
NiSource Inc NI delivered net operating earnings of 9 cents per share in third-quarter 2020, which surpassed the Zacks Consensus Estimate of 2 cents by 85.7%. On a GAAP basis, the company reported a loss of 49 cents per share compared witha loss of 2 cents in the year-ago quarter
Parsley Energy, Inc. PE recently delivered impressive third-quarter 2020 earnings. However, the pleasing results could not drive the stock much so far as there has been no major price change since the earnings release on Oct 28.
Investors are always looking for stocks that are poised to beat at earnings season and ArcBest Corporation ARCB may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because ArcBest Corporation is see
CNA Financial Corporation CNA reported third-quarter 2020 core earnings of 71 cents per share, which beat the Zacks Consensus Estimate of 62 cents by 14.5%. However, the bottom line decreased 38.8% year over year. The quarter witnessed higher premiums across most of its segments
NuVasive, Inc. NUVA delivered third-quarter 2020 adjusted earnings per share of 55 cents, down 6.8% from the year-ago figure. However, the figure beat the Zacks Consensus Estimate of earnings of 27 cents per share.
Investors are always looking for stocks that are poised to beat at earnings season and Welbilt, Inc. WBT may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Welbilt is seeing favorable earni
Ligand Pharmaceuticals Incorporated LGND reported third-quarter 2020 adjusted earnings of $1.04 per share, which missed the Zacks Consensus Estimate of $1.06. The company had reported adjusted earnings of 49 cents in the year-ago quarter.
The ODP Corporation ODP is likely to register a decline in the top line when it reports third-quarter 2020 numbers on Nov 5, before the market opens. The Zacks Consensus Estimate for revenues is pegged at $2,469 million, indicating a decline of 11.3% from the prior-year reported
Ready Capital Corporation RC is scheduled to report third-quarter 2020 results on Nov 4, after the closing bell. The company’s quarterly earnings per share (EPS) is expected to have declined while net interest income (NII) might havewitnessed year-over-year increase.
If you are anything like me, the overwhelming feeling you have at this point about the election is the kind of fear that leaves an empty feeling in the pit of your stomach. We are afraid of losing money due to market volatility and maybe even a collapse once the election is over.
B&G Foods, Inc. BGS is likely to report an increase in the top and bottom lines when it releases third-quarter 2020 numbers on Nov 5, after the closing bell. The Zacks Consensus Estimate for earnings has remained unchanged in the past 30 days at 64 cents per share, which sugg
American Equity Investment Life Holding Company AEL reported third-quarter 2020 adjusted net earnings of 99 cents per share, which missed the Zacks Consensus Estimate by 8.3%. The bottom line decreased 39.4% on a year-over-year basis.The quarter witnessed lower investment spread
Inseego INSG is set to report third-quarter 2020 results on Nov 5.The Zacks Consensus Estimate for revenues is currently pegged at $81.7 million, which suggests an increase of 30.2% from the year-ago quarter’s reported figure.For the quarter under review, the consensus mark for
ResMed Inc. RMD announced strong first-quarter fiscal 2021 results, wherein adjusted earnings per share (EPS) came in at $1.27, up 37% year over year. The metric also beat the Zacks Consensus Estimate by 29.6%.